Berliner Boersenzeitung - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.30605
AFN 77.455431
ALL 96.368843
AMD 446.825609
ANG 2.098861
AOA 1075.194297
ARS 1684.256833
AUD 1.75871
AWG 2.113454
AZN 1.990675
BAM 1.954163
BBD 2.357215
BDT 143.020165
BGN 1.955393
BHD 0.442026
BIF 3459.001738
BMD 1.172513
BND 1.513838
BOB 8.087224
BRL 6.349745
BSD 1.170314
BTN 105.638487
BWP 16.520088
BYN 3.433823
BYR 22981.246248
BZD 2.353818
CAD 1.612973
CDF 2620.565058
CHF 0.932962
CLF 0.027339
CLP 1072.493319
CNY 8.275653
CNH 8.268371
COP 4459.358408
CRC 582.814151
CUC 1.172513
CUP 31.071583
CVE 110.172687
CZK 24.225634
DJF 208.404491
DKK 7.470031
DOP 74.947522
DZD 152.069003
EGP 55.74336
ERN 17.587688
ETB 182.244576
FJD 2.663717
FKP 0.873318
GBP 0.876851
GEL 3.168164
GGP 0.873318
GHS 13.435742
GIP 0.873318
GMD 85.593444
GNF 10179.470725
GTQ 8.96349
GYD 244.814872
HKD 9.128872
HNL 30.812314
HRK 7.533513
HTG 153.270269
HUF 383.949754
IDR 19529.662388
ILS 3.757716
IMP 0.873318
INR 106.095444
IQD 1533.115418
IRR 49374.504122
ISK 148.206273
JEP 0.873318
JMD 187.502094
JOD 0.831307
JPY 182.852189
KES 150.926355
KGS 102.536535
KHR 4685.054462
KMF 492.45513
KPW 1055.256887
KRW 1731.578572
KWD 0.359668
KYD 0.975283
KZT 609.39939
LAK 25383.73123
LBP 104804.385472
LKR 361.926745
LRD 206.56692
LSL 19.820193
LTL 3.462125
LVL 0.709241
LYD 6.356647
MAD 10.76548
MDL 19.9313
MGA 5190.62869
MKD 61.534638
MMK 2462.590834
MNT 4159.343647
MOP 9.38044
MRU 46.393325
MUR 53.841242
MVR 18.068604
MWK 2029.39094
MXN 21.161231
MYR 4.807886
MZN 74.924535
NAD 19.820193
NGN 1700.342027
NIO 43.063917
NOK 11.861178
NPR 169.022099
NZD 2.017765
OMR 0.450856
PAB 1.170319
PEN 3.944495
PGK 4.965818
PHP 69.261539
PKR 329.157998
PLN 4.223168
PYG 7998.264228
QAR 4.265426
RON 5.089523
RSD 117.366736
RUB 93.397389
RWF 1703.465419
SAR 4.399723
SBD 9.650473
SCR 15.979173
SDG 705.269084
SEK 10.892648
SGD 1.514641
SHP 0.879688
SLE 28.264217
SLL 24587.000022
SOS 667.637746
SRD 45.244327
STD 24268.642774
STN 24.479385
SVC 10.24042
SYP 12966.090323
SZL 19.814313
THB 36.957449
TJS 10.790559
TMT 4.103794
TND 3.431525
TOP 2.823129
TRY 50.060647
TTD 7.942345
TWD 36.573601
TZS 2884.366813
UAH 49.399998
UGX 4161.513111
USD 1.172513
UYU 46.081389
UZS 14068.212388
VES 310.404955
VND 30844.1155
VUV 142.444053
WST 3.264212
XAF 655.405048
XAG 0.01819
XAU 0.000271
XCD 3.168774
XCG 2.109233
XDR 0.815114
XOF 655.405048
XPF 119.331742
YER 279.49766
ZAR 19.7712
ZMK 10554.022157
ZMW 26.830405
ZWL 377.548567
  • SCS

    0.0200

    16.14

    +0.12%

  • RYCEF

    -0.1000

    14.64

    -0.68%

  • RBGPF

    0.0000

    81.17

    0%

  • NGG

    0.0500

    74.69

    +0.07%

  • BCC

    -0.7500

    76.26

    -0.98%

  • VOD

    -0.0200

    12.54

    -0.16%

  • CMSC

    0.1300

    23.43

    +0.55%

  • AZN

    -1.2200

    90.29

    -1.35%

  • GSK

    0.4700

    48.88

    +0.96%

  • RIO

    0.5000

    76.74

    +0.65%

  • BCE

    0.2100

    23.4

    +0.9%

  • JRI

    0.0000

    13.72

    0%

  • CMSD

    0.1200

    23.4

    +0.51%

  • BTI

    -0.3900

    58.37

    -0.67%

  • RELX

    0.2000

    40.28

    +0.5%

  • BP

    -0.3500

    35.53

    -0.99%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

(H.Schneide--BBZ)